Elsevier Business Intelligence, an Elsevier company, has announced that it will host the 'IN3 Europe' Investor Conference in Paris. The event is scheduled for March 15-16, 2011, at Le Meridien Montparnasse Hotel, Paris.
Medical device start-ups continue to face intense competition for a finite amount of available funding. IN3 events offer a platform for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world. Leading venture capital firms and corporate acquirers are expected to attend IN3 Europe to hear about the latest innovations and investment opportunities from more than 40 emerging medical technology companies seeking funding and/or strategic partnerships.
Medtech innovator presentations are now mixed within the same time block as VCs, allowing emerging companies to get in front of more potential investment suitors. IN3 Europe has added more plenary/panel sessions to benefit the needs of all audience members. Top industry leaders will speak about regulatory issues, hot investment areas, real-life case studies on investing and M&A, philosophy to investments, and more.
Elsevier Business Intelligence, an Elsevier company, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing a combination of news and information together with penetrating insight and analysis.
Search for more Conferences
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
